CIK 0001933567
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Neuraxis, INC
Sign in to watch- Ticker
- NRXS
- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455079684
- Phone
- +1 812-689-0791
- Business address
- 11611 N. MERIDIAN ST, SUITE 330, CARMEL, IN, 46032
- 4 Grant or award Director acquired 21,598 shares (grant or award)
- 4 Grant or award Director acquired 21,598 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 80,000 shares at an average $4.79 ($382,800)
- 4 Grant or award Director acquired 21,598 shares (grant or award)
- 4 Grant or award Director acquired 21,598 shares (grant or award)
- 4 Open-market buy Director bought 286,138 shares at $3.52 ($1,007,206)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 13,157 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 13,157 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 13,157 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 821,327 shares at $2.25 ($1,847,986)
- 4 Open-market buy 10% owner bought 355,556 shares at $2.25 ($800,001)
- 4 Open-market buy 10% owner bought 18,065 shares at $1.73 ($31,251)
- 3 Insider Initial Statement of Ownership
Page 2 of 4 · 61 filings